Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Y-Biologics Inc. (338840)
Market Open
11 Aug, 06:30
KRX SM
All
(1)
KR
(1)
KRX SM
Primary
₩
11,280.
00
-90
-0.7916%
₩
480.62B
Market Cap
-
P/E Ratio
-
Div Yield
70,239
Volume
-
Eps
₩
11,370
Previous Close
Watching
Watch
Add Transaction
Day Range
10,870
11,300
Year Range
7,230
38,000
Want to track
338840
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Statistics
Historical Data
Y-Biologics Inc. (338840) Statistics
Valuation metrics
Market Cap
480.62B
Enterprise value
437.08B
Trailing P/E (ttm)
-66.86
Forward P/E
-
PEG ratio
-0.04
Price/Sales (ttm)
127.28
Price/Book (mrq)
31.68
Enterprise Value/Revenue
121.02
Enterprise Value/EBITDA
-64.84
Overview
Shares outstanding
14.95M
Float
10.55M
Shares short
-
% Held by insiders
0.29%
% Held by institutions
0.01%
Average volume (10 days)
276.53K
Average volume (90 days)
275.65K
Price summary
52-Week low
7,230
52-Week high
38,000
Beta
2.51
50-Day moving average
26,613
200-Day moving average
18,949.15
Financials
Fiscal year
Fiscal year ends
31 Dec 2024
Most recent quarter (mrq)
30 Sep 2025
Profitability
Profit margin
-2.42%
Operating margin
-2.83%
Operational effectiveness
Return on assets
-0.14%
Return on equity
-0.49%
Income Statement
Revenue (ttm)
3.61B
Revenue per share (ttm)
243.18
Quarterly revenue growth (yoy)
-0.72%
Gross profit (ttm)
2.64B
EBITDA
-6.74B
Net income to common (ttm)
-8.73B
Diluted EPS (ttm)
-511
Quarterly earnings growth (yoy)
-0.72%
Balance Sheet
Total cash (mrq)
42.27B
Total cash per share (mrq)
2,824.56
Total debt (mrq)
19.15B
Total Debt/Equity (mrq)
139.03
Current ratio (mrq)
1.16%
Book value per share (mrq)
920.23
Cash Flow
Cash flow statement
-5.26B
Levered free cash flow (LFCF)
12.48B